Search
Abbott Laboratories
ABTAdd to Watchlist
92.165USD
+1.425+1.57%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
160.56BMarket Cap
25.58P/E TTM
More Details of Abbott Laboratories Company
Abbott Laboratories is an American multinational health care and medical devices corporation headquartered in Abbott Park, Illinois. Founded in 1888 by Chicago physician Wallace Calvin Abbott, the company initially focused on formulating known drugs. Today, it offers medical devices, diagnostics, branded generic medications, and nutritional products. In 2013, Abbott separated its research-based pharmaceuticals division into AbbVie.
Abbott's product lineup includes Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT, and MitraClip.
Abbott Laboratories Info
Ticker SymbolABT
Company nameAbbott Laboratories
IPO dateApr 06, 2073
CEOFord (Robert B)
Number of employees114000
Security typeOrdinary Share
Fiscal year-endApr 06
Address100 Abbott Park Road
CityABBOTT PARK
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code60064-3500
Phone12246676100
Websitehttps://www.abbott.com
Ticker SymbolABT
IPO dateApr 06, 2073
CEOFord (Robert B)
Company Executives of Abbott Laboratories
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
90.41K
+20.44%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
76.84K
-1.49%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
71.54K
+28.74%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
--
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
36.34K
+6.29%
Mr. John G. Stratton
Mr. John G. Stratton
Independent Director
Independent Director
23.32K
+8.58%
Ms. Michelle A. Kumbier
Ms. Michelle A. Kumbier
Independent Director
Independent Director
18.00K
+12.70%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
90.41K
+20.44%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
76.84K
-1.49%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
71.54K
+28.74%
FAQs
Who are the top five shareholders of Abbott Laboratories?
The top five shareholders of Abbott Laboratories are: Mr. Daniel J. Starks
How many institutions hold shares of Abbott Laboratories (ABT)?
As of 2026Q1, 4859 institutions hold shares of Abbott Laboratories, with a combined market value of approximately 1.25B, accounting for 71.75% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -187252308.00.
What is the biggest source of revenue for Abbott Laboratories?
In 2026Q1, the Diabetes Care business generated the highest revenue for Abbott Laboratories, amounting to 8.00B and accounting for 18.04% of total revenue.